Cigna Corp’s share of pre-conference trading rose 0.2% as the healthcare company reported higher-than-expected quarterly earnings and revenue and provided optimistic profit prospects for the year.
Net income rose to $ 1.18 billion, or $ 3.68 a share, from $ 1.16 billion, or $ 3.30, a year earlier.
Excluding one-off, adjusted earnings per share stood at $ 6.01, well above the convergent estimates of $ 5.18.
Total revenue rose 7.4% to $ 44.01 billion, compared with estimates for $ 43.39 billion, as pharmacy revenue rose 9.5% to $ 30.70 billion.
For 2022, the company expects adjusted earnings per share of “at least” $ 22.6, higher than the estimates for $ 22.48.
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
